APA (7th ed.) Citation

RL, L., QC, S., K, Y., L, W., KL, J., L, X., & YF, Y. (2026). Empagliflozin Supplementation in Cardioplegic Solution Improves Donor Heart Preservation by Maintaining Mitochondrial Homeostasis. Cardiovascular drugs and therapy, 40(4), 1457. https://doi.org/10.1007/s10557-026-07834-1

Chicago Style (17th ed.) Citation

RL, Liu, Song QC, Yang K, Wang L, Jiao KL, Xie L, and Yang YF. "Empagliflozin Supplementation in Cardioplegic Solution Improves Donor Heart Preservation by Maintaining Mitochondrial Homeostasis." Cardiovascular Drugs and Therapy 40, no. 4 (2026): 1457. https://doi.org/10.1007/s10557-026-07834-1.

MLA (9th ed.) Citation

RL, Liu, et al. "Empagliflozin Supplementation in Cardioplegic Solution Improves Donor Heart Preservation by Maintaining Mitochondrial Homeostasis." Cardiovascular Drugs and Therapy, vol. 40, no. 4, 2026, p. 1457, https://doi.org/10.1007/s10557-026-07834-1.